Dr. Robin Smith Joins Hooper Holmes as a Board Advisor

OLATHE, Kan., March 16, 2017 (GLOBE NEWSWIRE) -- Hooper Holmes, Inc. HH is pleased to welcome Robin L. Smith, M.D. as a board advisor to assist with the assessment of strategic expansion opportunities in the health and well-being market.

"As we prepare to merge with Provant Health Solutions, LLC and continue to create one of the largest, pure-play health and wellness companies in the U.S., we welcome Dr. Smith as a board advisor," said Henry Dubois, President and CEO of Hooper Holmes. "Dr. Smith's expertise in healthcare and innovative clinical-based solutions, as well as her strong track record building, leading and assisting a variety of organizations and companies will provide additional insight on new products and potential services the Company can offer to clients to drive increased revenues and margins.  I look forward to working closely with Dr. Smith as we focus on profitably growing our business."

Dr. Smith added, "As the health and wellness market continues to grow, employers and insurers are looking for ‘value based' care, Hooper Holmes has a compelling market opportunity.  I look forward to collaborating with the team to expand their health and well-being solutions to reduce the chronic disease epidemic our country is facing and empower employees to improve their individual health."

Dr. Smith has vast experience in a multitude of leadership and strategic roles and is a renowned global thought leader in the regenerative medicine industry, one of the fastest growing segments of modern-day medicine.  Dr. Robin L. Smith received her M.D. from Yale University and an M.B.A. from the Wharton School of Business. She maintains a regular column on these topics for The Huffington Post and is the recipient of many accolades including the 2014 SmartCEO Brava! Award, which recognizes top women business leaders in the Greater New York area. She was also a finalist for the 2014 EY Entrepreneur of the Year award for the New York area, recognizing entrepreneurs who demonstrate excellence and success in the areas of innovation, financial performance and personal commitment to their businesses and communities.

Dr. Smith has extensive history serving in executive and board level capacities for various medical enterprises and healthcare-based entities.  She founded and has served as Chairman of the Board and President of The Stem for Life Foundation (SFLF) since its inception, an organization which is devoted to fostering global awareness of the potential for regenerative medicine to treat and cure a range of deadly diseases and debilitating medical conditions.  She is expanding SFLF's mission further under the Cura Foundation where she serves as President and Chairman.  Their efforts are focused on bringing resources to fund cell therapy clinical trials and assist in accelerating enrollment and completion.  Dr. Smith also serves as Chairman for MYnd Analytics, Inc., a predictive analytics company that developed a decision support system to help physicians reduce trial and error treatment in mental health.  Recently Hooper Holmes and MYnd Analytics announced a strategic partnership whereby the Hooper Holmes national network of health professionals will provide on-site or in-home EEG services for MYnd Analytics nationally.

About Hooper Holmes

Hooper Holmes mobilizes a national network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, employers and brokers, government organizations and academic institutions nationwide. Under the Accountable Health Solutions brand, the Company combines smart technology, healthcare and behavior change expertise to offer comprehensive health and wellness programs that improve health, increase efficiencies and reduce healthcare delivery costs. www.hooperholmes.com 

This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intends," "plan," and "will" or, in each case, their negative, and other variations or comparable terminology.  These forward-looking statements include all statements other than historical facts.   Any forward-looking statement made by management during this call is not a guarantee of future performance, and actual results may differ materially from those expressed in or suggested by the forward-looking statements, as a result of various factors, including, without limitation the factors discussed in the "Risk Factors" section of the company's Annual Report on Form 10-K for the year ended December 31, 2016, as the same may be updated from time-to-time in subsequent filings with the Securities and Exchange Commission. Any forward-looking statement made by management on this call speaks only as of the date hereof, and the Company has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. In addition, management uses the non-GAAP performance measures EBITDA and Adjusted EBITDA in this press release.

For further information:

Hooper Holmes
Henry E. Dubois
President and CEO
(913) 764-1045

Investors: Andrew Berger
S.M. Berger & Company
(216) 464-6400

Investors: Scott Gordon
CORE IR
(516) 222-2560